http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6dbdd7f29c0d7873a2feae4cce2e2d48
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ho |
| name | Vincent Ho |
| given-name | Vincent |
| organization-name | From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; the Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; the Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA; the Department of Ophthalmology, Brigham and Women's Hospital, Boston, MA; the Department of Rheumatology, Brigham and Women's Hospital, Boston, MA; and the Department of Medicine, Stanford University, Palo Alto, CA. School of Medicine, Western Sydney University, Campbelltown, Australia;; Department of Gastroenterology and Hepatology, Campbelltown Hospital, Campbelltown, Australia; Department of Genetics, Yale School of Medicine, New Haven, CT 06510, USA. Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and Gastroenterology Campbelltown Hospital Sydney New South Wales Australia; School of Medicine Western Sydney University Sydney New South Wales Australia Department of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; Regenerative Medicine Laboratory, School of Medicine, Western Sydney University, Campbelltown, NSW, Australia; South West Surgery, Campbelltown Private Hospital, Campbelltown, NSW, Australia Department of Gastroenterology Campbelltown Hospital Campbelltown New South Wales Australia; Western Sydney University Campbelltown New South Wales Australia School of Medicine, James Cook University, Cairns, Queensland, Australia. Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada Western Sydney University Sydney New South Wales Australia Division of Dermatology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA; Department of Dermatology, University of British Columbia, Vancouver, BC From Dermatrials Research, Hamilton, ON; Lynde Centre for Dermatology, Markham, ON; Department of Dermatology, Hôpital de l'Enfant-Jesus, Quebec City, QC; Department of Dermatology, Laval University, Quebec City, QC; Department of Dermatology, and Skin Science, University of British Columbia, Vancouver, BC; The Skin Care Centre, Vancouver, BC; Institute of Cosmetic & Laser Surgery, Oakville, ON; and Amgen Canada Inc., Mississauga, ON School of Medicine, Western Sydney University, Sydney, Australia; Gastroenterology, Campbelltown Hospital, Campbelltown, Australia School of Medicine Western Sydney University Campbelltown New South Wales Australia; Campbelltown Private Hospital Campbelltown New South Wales Australia Department of Dermatology and Skin Science, University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, BC, Canada From the Health Outcomes and PharmacoEconomics (HOPE) Research Centre, Division of Clinical Pharmacology, Department of Medicine, and Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON; The Skin Care Centre, University of British Columbia, Vancouver, BC; Lynderm Research Inc., Markham, ON; Centre de recherche dermatologique du Quebec metropolitain, Quebec City, QC; and Department of Pharmacology, University of Toronto, Toronto, ON Center for Hematologic Oncology Dana‐Farber Cancer Institute Boston Massachusetts From the Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC; and Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON School of Medicine, Western Sydney University, Campbelltown, NSW, Australia From the Department of Medical Oncology and Department of Biostatistical Science, Dana-Farber Cancer Institute; and the Department of Medicine, Brigham and Women's Hospital, Boston, MA. Dana-Farber Cancer Institute, Boston, MA; Yale School of Medicine From the Department of Surgery, Division of Urology and Departments of Radiology and Hematology/Oncology, Madigan Army Medical Center, Tacoma, Washington Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada Rafael Bejar and Bennett Caughey, University of California at San Diego, La Jolla, CA; Kristen E. Stevenson, R. Coleman Lindsley, Brenton G. Mar, David P. Steensma, Jerome Ritz, Robert Soiffer, Joseph H. Antin, Edwin Alyea, Philippe Armand, Vincent Ho, John Koreth, Donna Neuberg, and Corey S. Cutler, Dana-Farber Cancer Institute; R. Coleman Lindsley and Benjamin L. Ebert, Brigham and Women's Hospital, Harvard Medical School, Boston; Petar Stojanov, Gad Getz, and Benjamin L. Ebert, Broad Institute,... Department of Adult Oncology, Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. James Cook University, Department of Medicine, Cairns Base Hospital, Cairns, Queensland, Australia. Vincent_Ho@health.qld.gov.au From Probity Medical Research, Waterloo, ON; Dermatology Clinic, Moncton, NB; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC; Amgen Canada, Mississauga, ON; and Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC 12Dana-Farber/Brigham and Women's Cancer Center; Barbara Melosky, Vincent Ho, Cheryl Ho, Nevin Murray, Sophie Sun, and Janessa J. Laskin, British Columbia Cancer Agency (BCCA) Vancouver Centre, Vancouver; Helen Anderson, BCCA Vancouver Island Centre, Victoria; Wendy Lam, Burnaby Regional Hospital, Burnaby; Christopher W. Lee, BCCA Fraser Valley Cancer Centre, Surrey; Robert Winston, BCCA Abbotsford Centre, Abbotsford, British Columbia; Ronald L. Burkes, Mount Sinai Hospital; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario; Quincy... Department of Medical Oncology, Division of Hematological Malignancies, and Christopher J. Gibson, R. Coleman Lindsley, Brenton G. Mar, Jiantao Shi, Ann S. Lacasce, Arnold S. Freedman, David C. Fisher, Eric Jacobsen, Philippe Armand, Edwin P. Alyea, John Koreth, Vincent Ho, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Sarah Nikiforow, Franziska Michor, and Donna Neuberg, Dana-Farber Cancer Institute; Jiantao Shi and Franziska Michor, Harvard T.H. Chan School of Public Health; Siddhartha Jaiswal, Elizabeth A. Morgan, and Benjamin L. Ebert, Brigham and Women’s Hospital,... Department of Dermatology and Skin Science, University of British Columbia , Vancouver, BC , Canada Skin Care Centre, University of British Columbia, Vancouver, Canada Dana-Farber/Brigham and Women’s Cancer Center 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Western Sydney University, Sydney, Australia; From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute; the Department of Medicine, Brigham and Women's Hospital; and Harvard Medical School, Boston, MA. Department of Dermatology, Hôpital de l'Enfant-Jésus du CHA, and Départment de Medicine, Laval University, Quebec City, QC School of Medicine, Western Sydney University, NSW, Australia; South Western Sydney Metabolic Rehabilitation and Bariatric Program, Camden Hospital, NSW, Australia Division of Dermatology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada Campbelltown and Camden Hospitals Campbelltown New South Wales Australia; School of Medicine Western Sydney University Sydney New South Wales Australia From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. From Lynderm Research, Markham, ON; The Guenther Dermatology Research Centre, London, ON; University Hospital of Heidelberg, Heidelberg, Germany; McGill University Health Centre, Montreal, QC; Centre de Recherche Dermatologique du Québec Metropolitain, Qeubec, QC; NewLab Research, St. John's, Newfoundland; Bispebjerg Hospital, Copenhagen, Denmark; Kirk Barber Research, Calgary, AB; Innovaderm Research, Montreal, QC; University of British Columbia, Vancouver, BC; University of Manitoba, Winnipeg, MB; and... Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Madigan Army Medical Center, Tacoma, Washington. Richtek Technology Corporation, Taiwan, China |
Incoming Links
Total number of triples: 208.